The Evils of Open-Access in the Developing World

I recently chastised Harold Varmus for equating open-access publishing with pay-to-publish. While open-access journals do tend to have higher author charges than pay-access journals, many journals make money from both author charges and subscriber charges. That is, they are pay to publish and pay to read.

A letter to Nature this week challenges the idea that open-access publishing is good for the developing world by assuming the same fallacy as Varmus (doi:10.1038/453450c). Raghavendra Gadagkar, of the Indian Institute of Science, argues that the pay to publish model prevents underfunded researchers from publishing their work. This assumes that open-access publishers have a limited number of waivers for author fees. He would prefer journals publish articles free of charge and charge for access to the articles. In short, Gadagkar values authorship over readership.

Gadagkar makes a valid point -- that a pay to publish model could severely limit the academic output from developing countries. However, it's unclear whether the open-access publishers have a limited number of fee waivers to offer. Will the open-access publishing model collapse if too many authors require fee waivers? Where is the tipping point? And will well funded researchers be willing to bear the burden of paying the author charges, indirectly, of poorly funded researchers?

More like this

Harold Varmus is one of the most high profile advocates of open access to biomedical research. As one of the cofounders of the Public Library of Science (PLoS), he has played an important role in making published results freely available to all. And he's a Nobel Laureate, which ain't too shaby…
There is one small event from the conference (Publishing in the New Millennium: A Forum on Publishing in the Biosciences) that I would like to share with you. I asked Emilie Marcus, head editor of Cell, a few questions. But before we go there I'd like to delve into one aspect of the whole open…
OA pillars The following are excerpts from the journal Nature regarding the Public Library of Science. These were located with a simple search for the phrase "Public Library of Science." For each item, I provide the source, and a selected bit of text. I have no selection criteria to report…
As many of you may be aware, yesterday was the first day of the implementation of the new NIH law which requires all articles describing research funded by NIH to be deposited into PubMed Central within 12 months of publication. Folks at SPARC have put together a list of resources one can consult…

Indeed -- this all rests on an assumption which at present is there is no reason to believe is or will be true. Bearing in mind BMC and (so far as I know) PLoS automatically waive all fees for authors in developing countries, I don't think any authors are going to find themselves with nowhere at all to publish. Perhaps they will miss out on their first choice (i.e. highest IF) journal, but that's an injustice I'd have a hard time getting worked up about.

And regarding whether well funded researchers will put up with subsidising poorly funded researchers: it looks like the more relevant question will soon be whether funding agencies in rich countries will put up with subsidising research from poor countries.

My publisher does limit the waivers granted and they are usually granted to authors in the developing world. I don't know of any instances in our journal, however, where an author in the developing world couldn't publish because of a waiver not being granted. Pay to publish versus pay to read are just business models used to support (or make a lot of money) from scientific publishing. There is always a trade-off. At the moment the trade-off for Open Access (whatever the model) strongly favors scientists in the developing world IME.

This doesn't sound well thought out - if they pay to publish, then everyone in the developing country can read. Surely that's better for everyone, the researchers included, than publishing freely in journals they can't afford to read.

I fully agree with Dr. Gadagkar - if I, from a developing country, do not get a waiver, why on earth should I cough up hard-to-get money for it? If the matter of my paper is really good (and the abstract well written), people will pay the $30 to read it. As it is, due to lack of infrastructure and funds, my experiments too are constrained.

tomjoe,

I agree with you. However, you assume that waivers will be denied. It's my experience that they rarely are when a waiver is justified.